| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk
|
Schoen, Martin W.
|
|
2018
|
68 |
C |
p. 72-78
|
artikel
|
| 2 |
AML refractory to primary induction with Ida-FLAG has a poor clinical outcome
|
Kavanagh, Simon
|
|
2018
|
68 |
C |
p. 22-28
|
artikel
|
| 3 |
An autologous tumor vaccine for CLL
|
Zhu, Fang
|
|
2018
|
68 |
C |
p. 40-47
|
artikel
|
| 4 |
Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia
|
Choi, Eun-Ji
|
|
2018
|
68 |
C |
p. 51-56
|
artikel
|
| 5 |
Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55–65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia
|
Ribera, Josep-Maria
|
|
2018
|
68 |
C |
p. 79-84
|
artikel
|
| 6 |
Corrigendum to ’CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia’ [leukemia research. 2018; 66: 15-19]
|
Huang, Jinjin
|
|
2018
|
68 |
C |
p. 120
|
artikel
|
| 7 |
Early preemptive ICU admission for newly diagnosed high-risk acute myeloid leukemia patients
|
Saillard, Colombe
|
|
2018
|
68 |
C |
p. 29-31
|
artikel
|
| 8 |
Editorial Board
|
|
|
2018
|
68 |
C |
p. ii
|
artikel
|
| 9 |
Enhanced perforin expression associated with dasatinib therapy in natural killer cells
|
Iriyama, Noriyoshi
|
|
2018
|
68 |
C |
p. 1-8
|
artikel
|
| 10 |
High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype
|
Sarova, Iveta
|
|
2018
|
68 |
C |
p. 85-89
|
artikel
|
| 11 |
Interpretation of clinical endpoints in trials of acute myeloid leukemia
|
Medeiros, Bruno C.
|
|
2018
|
68 |
C |
p. 32-39
|
artikel
|
| 12 |
It is not just the number of metaphases that matters
|
Costa, Marília Braga
|
|
2018
|
68 |
C |
p. 70-71
|
artikel
|
| 13 |
Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials
|
Knauf, Wolfgang
|
|
2018
|
68 |
C |
p. 90-97
|
artikel
|
| 14 |
New synergistic combinations of differentiation-inducing agents in the treatment of acute promyelocytic leukemia cells
|
Amanzadeh, Amir
|
|
2018
|
68 |
C |
p. 98-104
|
artikel
|
| 15 |
No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia
|
Dai, Qingkai
|
|
2018
|
68 |
C |
p. 57-61
|
artikel
|
| 16 |
Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome
|
Ganzel, Chezi
|
|
2018
|
68 |
C |
p. 9-14
|
artikel
|
| 17 |
Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway
|
Lam, Chung Fan
|
|
2018
|
68 |
C |
p. 112-119
|
artikel
|
| 18 |
Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS
|
Boch, Tobias
|
|
2018
|
68 |
C |
p. 62-69
|
artikel
|
| 19 |
Similar incidence of typhlitis in patients receiving various doses of daunorubicin or idarubicin as induction for acute myeloid leukemia
|
Seddon, Amanda N.
|
|
2018
|
68 |
C |
p. 48-50
|
artikel
|
| 20 |
Targeting histone demethylases KDM5A and KDM5B in AML cancer cells: A comparative view
|
Shokri, Gelareh
|
|
2018
|
68 |
C |
p. 105-111
|
artikel
|
| 21 |
ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation
|
Liu, Jia
|
|
2018
|
68 |
C |
p. 15-21
|
artikel
|
Tijdschrift beschrijving